Clinical Trial: Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]GRT6019

U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT07479745) titled 'Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]GRT6019' on March 13.

Brief Summary: The main purpose of this study is to determine the mass balance recovery and the metabolite profile of a single dose of carbon-14 ([14C]) GRT6019

Study Start Date: March 26

Study Type: INTERVENTIONAL

Condition: Healthy Male Volunteers

Intervention: DRUG: [14C]GRT6019

Single administration in a single dosing period.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Grunenthal GmbH

Disclaimer: Curated by HT Syndication....